Long-Term Outcome by Risk Factors Using Conformal High Dose Rate Boost for Prostate Cancer

Reviewer: William Levin, MD
OncoLink
Ultima Vez Modificado: 8 de octubre del 2002

Translation for this article does not exist

Blogs

The Power of a Cancer Support Group
by Bob Riter
May 26, 2016